Towards better brain management: Nootropics

Current Medicinal Chemistry

Volumn 14, Issue 2, 2007, Pages 123-131

  Malik, Ruchi ^a   Sangwan, Abhijeet ^a   Saihgal, Ruchika ^a   Jindal, Dharam Paul ^a   Piplani, Poonam ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Antiamnesic activity; Cholinergic activators; CNS modulators; Metabolic enhancers; Neurotransmission substitution therapies; Nootropics; Paracetamol derivatives; Racetams

Indexed keywords

1 (2 NAPHTHYLOXYMETHYLCARBONYL)MORPHOLINE; 1 (2 NAPHTHYLOXYMETHYLCARBONYL)PYRROLIDINE; ACETAMIDE DERIVATIVE; ANIRACETAM; BIFEMELANE; BIOGENIC AMINE; CHOLINERGIC RECEPTOR STIMULATING AGENT; DEANOL; DIHYDROERGOTOXINE MESILATE; ETIRACETAM; EXCITATORY AMINO ACID; HUPERZINE A; IDEBENONE; INDELOXAZINE; MORPHOLINE DERIVATIVE; N,N DIMETHYL 2 (NAPHTHYLOXY)ACETAMIDE; NEBRACETAM; NEFIRACETAM; NEUROPEPTIDE; NEUROTRANSMITTER; NOOTROPIC AGENT; OXIRACETAM; PHOSPHATIDYLCHOLINE; PIRACETAM; PRAMIRACETAM; PSYCHOSTIMULANT AGENT; PYRROLIDINE DERIVATIVE; ROLZIRACETAM; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINPOCETINE;

CHEMICAL COMPOSITION; CLINICAL TRIAL; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG CLASSIFICATION; DRUG DESIGN; DRUG MECHANISM; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; LEARNING DISORDER; MEDICAL LITERATURE; MEDICAL RESEARCH; MEMORY CONSOLIDATION; MEMORY DISORDER; NEUROLOGIC DISEASE; NEUROTRANSMISSION; NONHUMAN; REVIEW;

COGNITION DISORDERS; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; HUMANS; LEARNING; MEMORY; NOOTROPIC AGENTS;

EID: 33846002757     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986707779313408     Document Type: Review

References (145)

1. Athina, A.G.; John, C.D.; Dmitri, F.; Irina, G.; Taissia, L.G.; Tatiana, G.; Valentina, K.; Alexey, L.; Fliur, Z.M.; Guenadij, M.; Vladimir, V.P.; Serghei, I.P.; Felix, S.; Tatiana, A.V.; Maria, T.; Liudmila, V. J. Med. Chem., 2004, 47(11), 2870.
2. McGaugh, J.L. Ann. Rev. Pharmacol., 1973, 13, 229.
3. Silva, A.J. J. Neurobiol., 2003, 54, 224.
4. Schacter, D.L. Am. Psychol., 1992, 47, 559.
5. Briggs, M.H.; Ketto, G. B. Psychol. Rev., 1962, 69, 539.
6. Josselyn, S.A.; Shi, C.; Carlezon, W.A.; Neve, R.L.; Nestler, E.J.; Davis, M. J. Neurosci., 2002, 21(7), 2404.
7. Marta, M.; Castellano, C.; Oliverio, A.; Pavone, F.; Pagella, P.G.; Brujani, M.; Pomponi, M. Life Sci., 1988, 48, 1921.
8. Grutzendler, J.; Morris, J.C. Drugs, 2001, 61(1), 41.
9. Brufani, M.; Filocamo, L.; Lappa, S.; Maggi, A. Drugs Future, 1997, 22, 397.
10. Mucke, H.A.M.; Castaner, J. Drugs Future, 1998, 23, 843.
11. Vernier, J.M.; Abdellaoni, H.E.; Holsenback, H.; Cosford, N.D.P.; Bleicher, L.; Barker, G.; Bontempi, B.; Noriega, L.C.; Menzaghi, F.; Rao, T.S.; Sacaan, A.I.; Suto, C.; Washburn, M.; Lloyd, G. K.; McDonald, I.A. J. Med. Chem., 1999, 42(10), 1684.
12. Okonjo, K.O.; Kuhlmann, J.; Maelicke, A. Eur. J. Biochem., 1991, 200, 671-677.
13. Andreani, A.; Leoni, A.; Locatelli, A.; Morigi, R.; Rambaldi, M.; Pietra, C.; Villetti,G. Eur. J. Med. Chem., 2000, 35, 77.
14. Nitta, A.; Murase, K.; Furukawa, Y.; Hayashi, K.; Hasegawa, T.; Nabeshima, T. Eur. J. Pharmacol., 1993, 250, 23.
15. Graul, A.; Prous, J.; Castaner, J. Drugs Future, 1998, 23, 41.
16. Graul, A.; Castaner, J. Drugs Future, 1996, 21, 911.
17. Popik, P.; Glick, S.D. Drugs Future, 1996, 21, 1109.
18. Peeke, S.C.; Peeke, H.V.S. Psychopharmacol., 1984, 84, 205.
19. Garvey, D.S.; Wasicak, J.T.; Michael, D.W.; Brioni, J.D.; Buckley, M.J.; Sullivan, J.P.; Carrera, G.M.; Holladay, M.W.; Arneric, S.P.; Williams, M. J. Med. Chem., 1994, 37, 1055.
20. Narayanan, T.K.; Aronstam, R.S. Neurochem. Res., 1984, 43, 1171.
21. Stern, R.G.; Davis, K.L., In Principles of pharmacology; Munson, P.L.; Muller, R.A.; Breese, G.R.; Eds.; Chapman and Hall an International Thomson Publishing Company: New York, pp.1726.
22. Michaeu, J.; Durkin, T.P.; Destrade, C.; Rolland, Y.; Jaffard, R. Pharmacol. Biochem. Behav., 1985, 23, 195.
23. Graul, A.; Castaner, J. Drugs Future, 1997, 22, 945.
24. Sterinberg, D.B.; Karol, D.; Novack, G.D.; McGaugh, J.L. Eur. J. Pharmacol., 1986, 129, 189.
25. Adolfsson, R.; Gottfries, C.G.; Roos, B.E.; Winblad, B. Br. J. Psychiatry, 1979, 135, 216.
26. Mucke, H.A.M.; Castaner, J. Drugs Future, 1998, 23, 1075.
27. Dehlin, O.; Hedenrud, B.; Jansson, P.; Norgard, J. Acta Psychiatr. Scand., 1985, 71, 190.
28. Bompani, R.; Scali, G. Curr. Med. Res. Opin., 1986, 10, 99.
29. David, G.; Friedman, J.C.; Milhand, G.; Marmo, E.; Pierre, R. Acta Ther., 1985, 11, 387.
30. Rolandi, E.; Francheschini, R.; Marabini, A.; Messina, V.; Bongera, P.; Barreca, T. Br. J. Clin. Pharmacol., 1984, 18, 236.
31. Starke, K. Annu. Rev. Pharmacol. Toxicol., 1981, 21, 7.
32. Yonkov, D.I.; Georgiev, V.P.; Kambourva, T. Meth. Find. Exp. Clin. Pharmacol., 1989, 11, 603.
33. Caamano, J.; Franco-Maside, A.; Fernandez-Nova, L.; Gomez, M.J.; Alvarez, X.A.; Takeda, M.; Prous, Jr.J.; Nishimura, T.; Winblad, B. Drugs Today, 1994, 30, 295.
34. Jarvik, M.E. Ann. Rev. Psychol., 1972, 23, 457.
35. Wolterink, G.; VanZanten, E.; Kamsteeg, H.; Radhakrishun, F.S.; VanRee, J.M. Brain Res., 1990, 507, 101.
36. Yorbrough, G.G.; Domara, N. Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 1985, 9, 285.
37. Fadden, A.I.; Jacobs, T.P. Neurology, 1985, 35, 1331.
38. Kadar, T.; Penke, B.; Kovacs, K.; Telegdy, G. Neuropeptides, 1984, 4, 127.
39. Wroblewski, T.; Silvestre, J. Drugs Future, 1998, 23, 284.
40. Shrotriya, R.C.; Cutler, N.R.; Sramek, J.J.; Veroff, A.E.; Hironaka, D.Y. Ann. Pharmacother., 1996, 30, 1376.
41. Etienne, P.E.; Zubenko, G.S. Trends Pharmacol. Sci., 1987, 8, 329.
42. Zubenko, G.C.; Nixon, R.A. Am. J. Psychiat., 1984, 171, 110.
43. Mondadori, C.; Etienne, P.E. Psychopharmacol. Losy (Berl.), 1990, 100, 301.
44. Hock, F.J.; Gerhards, H.J.; Wiemer, G.; Stehl, J.; Ruger, W.; Urbach, H. Eur. J. Pharmacol., 1989, 171, 79.
45. O'Doanell, V.M.; Pitts, W.M.; Fann, W.E. Clin. Neuropharmacol., 1986, 9, 65.
46. Evans, R.W.; Gualtieri, C.T.; Amara, I. Psychopharmacol., 1986, 90, 211.
47. Crook, T. Ann. N.Y. Acad. Sci., 1985, 444, 428.
48. Singh, G.P.; Sawhney, I.M.S.; Chopra, J.S. Drugs Bull., 1989, 12, 29.
49. Hill, R.A.; Wallace, L.J.; Miller, D.D.; Weinstein, D.M.; Shams, G.; Tai, H.; Layer, R.T.; Willins, D.; Uretsky, N.J.; Danthi, S.N. J. Med. Chem., 1997, 40, 3182.
50. Cai, S. X.; Huang, J. C.; Espitia, S. A.; Tran, M.; Hyin, V. I.; Hawkinson, J. E.; Woodward, R. M.; Weber, E.; Keana, J.F.W. J. Med. Chem., 1997, 40, 3679.
51. Kemp, J.A.; Foster, A.C.; Gill, R.; Woodruff, G.N. Trends Pharmacol. Sci., 1987, 8, 414.
52. Coan, E.J.; Saywood, W.; Collingridge, G.L. Neurosci. Lett., 1987, 80, 111.
53. Collingridge, G.L.; Bliss, T.V.P. Trends Neurosci., 1987, 10, 288.
54. Prakash, J.C.; Sirsi, M. J. Sci. Industr. Res., 1962, 21, 93.
55. Satyavati, G.V.; Raina, M.K.; Sharma, M. Eds., In Medicinal Plants of India, Cambridge Printing Works: Delhi, 1976; Vol 1, pp. 118.
56. Satyavati, G.V.; Raina, M.K.; Sharma, M. Eds., In Medicinal Plants of India, Cambridge Printing Works: Delhi, 1976; Vol 1, pp. 215.
57. Warrier, P.K.; Nambiar, V.P.K.; Ramankutty, C. Eds., In Indian Medicinal Plants, Orient Longman Ltd.: Chennai, 1994; Vol 3, pp. 11.
58. Warrier, P.K.; Nambiar, V.P.K.; Ramankutty, C. Eds., In Indian Medicinal Plants, Orient Longman Ltd.: Chennai, 1994; Vol 1, pp. 51.
59. Warrier, P.K.; Nambiar, V.P.K.; Ramankutty, C. Eds., In Indian Medicinal Plants, Orient Longman Ltd.: Chennai, 1994; Vol 2, pp. 52.
60. Barar, F.S.K.; Sharma, V.N. Indian J. Physiol. Pharmacol., 1965, 9, 99.
61. Satyavati, G.V.; Raina, M.K.; Sharma, M. Eds., In Medicinal Plants of India, Cambridge Printing Works, Delhi, 1976; Vol 1, pp. 276.
62. Ramteke, S.; Andrade, C.; Faruqui, S.; Joseph, J.; Venkataraman, B.V.; Rani, M.A.N. Indian J. Pharmacol., 1995, 27, 186.
63. Kulkarni, S.K.; Verma, A. Indian J. Physiol. Pharmacol., 1992, 36, 29.
64. Wu, C.R.; Hsieh, M.T.; Huang, S.C.; Peng, W.H.; Chang, Y.S.; Chen, C.F. Planta Med., 1992, 62, 317.
65. Saletu, B.; Grunberger, J. Ann. N.Y. Acad. Sci., 1985, 444, 406.
66. Joseph, G.V.R. Herald Health, 2003, 15.
67. Bologa, L., Sharma, J., Roberts, E. J. Neurosci. Res., 1987, 17, 225.
68. Gibbs, M.E.; Ng, K.T.; Andrew, R. J. Pharmacol. Biochem. Behav., 1986, 25, 823.
69. Toledo-Morrell, L.; Morrell, F.; Fleming, S.; Cohen, M.M. Behav. Neural. Biol., 1984, 42, 1.
70. Goto, M.; Demura, N; Sakaguchi, T. J. Pharmacobiodyn., 1985, 8, 73.
71. Sharma, A.; Parikh, V.; Singh, M. Indian J. Exp. Biol., 1997, 35, 1146.
72. Kubo, K.; Ikeda, J.; Shiozaki, S.; Shuto, K.; Oka, T.; Nakamizo, N. Jpn. J. Pharmacol., 1986, 40, 259.
73. Tablet, N.; Birks, J.; GrimleyEvans, J.; Orrel, M.; Spector, A. The Cochrane Library Issue, John Wiley and Sons Ltd.: Chichester, U.K., 2005.
74. Malouf, R.; Grimley Evans, J. The Cochrane Library Issue, John Wiley and Sons Ltd.: Chichester, U.K., 2005.
75. Malouf, R.; Areosa Sastre, A. The Cochrane Library Issue, John Wiley and Sons Ltd.: Chichester, U.K., 2005.
76. Malouf, R.; Grimley Evans, J.; Areosa Sastre, A. The Cochrane Library Issue, John Wiley and Sons Ltd.: Chichester, U.K., 2005.
77. Higgins, J.P.T.; Flicker, L. The Cochrane Library Issue, John Wiley and Sons Ltd.: Chichester, U.K., 2005.
78. Huppert, F.A.; Van Niekerk, J.K. In The Cochrane Library Issue, John Wiley and Sons Ltd.: Chichester, U.K., 2005.
79. Schindler, V.; Rush, D.K.; Fieldings, S. Drug Dev. Res., 1984, 4, 567.
80. Dimond, S.J. In Drugs to improve learning in man, in the neuropsychology of learning disorders, Knight, R.; Bakker, D. Eds.: Univ. Park, Baltimore, 1976; pp. 367.
81. Dimond, S.J.; Brouwers, E. Psychopharmacol. Losy (Berl.), 1976, 49, 307.
82. Amato, M.E.; Bandoli, G.; Grassi, A. Eur. J. Med. Chem., 1991, 26, 443.
83. Giurgea, C. In Current Development in Psychopharmacol., Essman, W.B.; Valzelli, L. Eds.; Spectrum Publications, Inc.: New York, 1976; Vol 3, pp. 221.
84. Giurgea, C.; Moyersoons, F. Arch. Int. Pharmacodyn. Ther., 1970, 188, 401.
85. Giurgea, C.; Salama, M. Prog. Neuro-Pharmac., 1977, 1, 235.
86. Coper, H.; Herrmann, W.M. Pharmacopsychiatry, 1988, 21, 212.
87. Parnetti, L.; Senin, U.; Mecocci, P. Drugs, 1997, 53, 752.
88. Croisile, B.; Trillet, M.; Fondarai, J.; Laurent, B.; Maugiuare, F.; Billardon, M. Neurology, 1993, 43, 301.
89. Carson, W.H.; Markowitz, J.S. Ann. Clin. Psychiat., 1996, 8, 41.
90. Baker, L.S. Am. J. Psychiat., 1996, 153, 844.
91. Goutiaev, A.; Senning, A. Brain Res. Rev., 1994, 19, 180.
92. Emmeneggar, H.; Ruge, M. W. Pharmacology, 1968, 1, 65.
93. Cheng, D.H.; Tang, X.C. Pharmacol. Biochem. Behav., 1998, 60, 377.
94. Nandy, K.; Schneider, F.H. Gerontology, 1978, 24, 66.
95. Yamamoto, M.; Shimizu, M.; Harda, M.; Terai, M.; Yamaguti, T. Kiso To Rinsyo, 1985, 19, 4563.
96. Tobe, A.; Egawa, M.; Hashimoto, N. Folia Pharmacol. Japan, 1983, 81, 421.
97. Sergio, W. Med. Hypoth., 1988, 26, 255.
98. Casey, D.E.; Denney, D. Engl. J. Med., 1974, 291, 797.
99. Manetti, D.; Ghelardini, C.; Bartolini, A.; Bellucci, C.; Dei, S.; Galeotti, N.; Gualtieri, F.; Romanelli, M. N.; Scapecchi, S.; Teodori, E. J. Med. Chem., 2000, 43, 1969.
100. Heise, G.A. Trends Pharmacol. Sci., 1987, 8, 65.
101. Mondadori, C. Crit. Rev. Neurobio., 1996, 10, 357.
102. Tacconi, M.; Wurtman, R. In Advances in Neurology, Fahn, M., Ed., Raven Press: New York, 1986; Vol 43, pp. 675.
103. Hershenson, F.M.; Marriott, J.G.; Moos, W.H. Ann. Reports Med. Chem., 1986, 21, 31.
104. Moyersoons, F.; Giurgea, C. Arch. Int. Pharmacodyn. Ther., 1974, 210, 38.
105. Pede, J.P.; Shimpfessel, L.; Crokoert, R. Arch. Int. Physiol. Biochem., 1971, 79, 1036.
106. Samorajski, T.; Vroulis, G.A.; Smith, R.C. Ann. N.Y. Acad. Sci., 1985, 444, 478.
107. Herrmann, W.M.; Kern, U. Nervenarzt, 1987, 58, 358.
108. Platel, A.; Jalfre, M.; Pawelec, C.; Roux, S.; Porsolt, R.D. Pharmacol. Biochem. Behav., 1984, 21, 209.
109. Fontani, G.; Grazzi, F.; Meucci, M. Life Sci., 1984, 35, 1183.
110. Pinza, M.; Farina, C.; Cerri, A.; Pfeiffer, U.; Riccaboni, M.T.; Banfi, S.; Biagetti, R.; Pozzi, O.; Magnani, M.; Dorigotti, L. J. Med. Chem., 1993, 36, 4214.
111. Altomare, C.; Carotti, A.; Casini, G.; Cellamare, S.; Ferappi, M.; Gavuzzo, E.; Mazza, F.; Pantaleoni, G.; Giorgi, R. J. Med. Chem., 1988, 31, 2153.
112. Butler, D.E.; Nordin, I.C.; L'Italien, Y.J.; Zweisler, L.; Poschel, P.H.; Marriott, J.G. J. Med. Chem., 1984, 27, 684.
113. Nappi, G.; Rabasseda, X.; Mealy, N. Drugs Today, 1994, 30, 469.
114. Pugsley, T.A.; Shich, Y.H.; Coughenour, L.; Stewart, S.F. Drug Dev. Res., 1983, 3, 407.
115. Funk, K.F.; Schmidt, J. Biomed. Biochem. Acta., 1988, 47, 417.
116. Mondadori, C. Brain Res., 1987, 435, 310.
117. Sansone, M.; Ammassari, T.M.; Oliverio, A. Arch. Int. Pharmacodyn., 1985, 278, 229.
118. Cumin, R.; Bandle, E.F.; Gamzu, E.; Haefley, W.E. Psychopharmacol. (Berlin), 1982, 78, 104.
119. Pontecorvo, M. J.; Evans, H.L. Pharmacol. Biochem. Behav., 1985, 22, 745.
120. Butler, D.E., U.S. Patent 4,638,006, Jan. 20, 1987.
121. Wolthius, O.L. Pharmacol. Biochem. Behav., 1981, 15, 247.
122. Hiramatsu, M.; Koide, T.; Ishihara, S.; Shiotani, T.K.; Nabeshima, T. Eur. J. Pharmacol., 1992, 216, 279.
123. Yoshii, M.; Watabe, S.; Murashima, Y.L.; Shiotani, T.; Tanaka, M. 4th IBRO world Cong. Neurosci. (July 9-14, Kyoto), 1995, Abst. A 4.35.
124. Aoshima, H.; Shingai, R.; Ban, T. Arzneim-Forsch Drug Res., 1992, 42, 775.
125. Villaroya, M.; Lopez, M. G.; Cano-Abad, M. F.; Garcia, A. G. Methods Mol. Biol., 1999, 114, 137.
126. Chavez-Noriega, L.E.; Gillespie, A.; Stauderman, K.A.; Crona, J.H.; O'Neil Claeps, B.; Elliott, K. J.; Reid, R.T.; Rao, T.S.; Veliçelebi, G.; Harpold, M.M.; Johnson, E.C.; Corey-Naeve, J. Neuropharmacology, 2000, 39, 2543.
127. Manning, T.J.Jr.; Sontheimer, H. J. Neurosci. Methods, 1999, 91, 73.
128. Kuntzweiler, T.A.; Arneric, S.P.; Donnelly-Roberts, D.L. Drug Dev. Res., 1998, 44, 14.
129. Whiteaker, K.L.; Gopalakrishnan, S.M.; Groebe, D.; Sheih, C.C.; Warrior, U.; Burns, D.J.; Coghlan, M.J.; Scott, V.E.; Gopalakrishnan, M. J. Biomol. Screen, 2001, 6, 305.
130. Baxter, D.F.; Kirk, M.; Garcia, A.F.; Raimondi, A.; Holmqvist, M.H.; Flint, K.K.; Bojanic, D.; Distefano, P.S.; Curtis, R.; Xie, Y. J. Biomol. Screen, 2002, 7, 79.
131. Lukas, R.J. J. Neurochem.,1986, 46, 1936.
132. Gotti, C.; Wanke, E.; Sher, E.; Fornasari, D.; Cabrini, D; Clementi, F. Biochem. Biophys. Res. Commun., 1986, 137, 1141.
133. Houghtling, R.A.; Davila-Garcia, M.I.; Kellar, K. J. Mol. Pharmacol., 1995, 48, 280.
134. Davies, A.R.L.; Hardick, D.J.; Blagbrough, I.S.; Potter, B.V.L.; Wolstenholme, J.; Wonnacott, S. Neuropharmacology, 1999, 38, 679.
135. Connolly, J.C.; Kennedy, C. Drugs Pharm. Sci., 1998, 89, 107.
136. Bertrand, D.; Buissand, B.; Krause, R.M.; Hu, H.Y.; Bertrand, S. J. Recept. Sig. Transd. Res., 1997, 17, 227.
137. Catterall, W.A. Biol. Chem., 1974, 1776.
138. Lukas, R. J.; Cullen, M. J. Anal. Biochem., 1988, 175, 212.
139. Veliçelebi, G.; Stauderman, K.A.; Varney, M.A.; Akong, M.; Hess, S. D.; Johnson, E. C. Methods Enzymol., 1999, 279, 20.
140. Minta, A.; Kao, J.P.; Tsien, R.Y. J. Biol. Chem., 1989, 264, 8171.
141. Grynkiewicz, G.; Poenie, M.; Tsien, R. Y. J. Biol. Chem., 1985, 260, 3440.
142. Gee, K. R.; Brown, K. A.; Chen, W. N. U.; Bishop-Stewart, J.; Gray, D.; Johnson, I. Cell Calcium, 2000, 27, 97.
143. Piplani, P.; Jindal, D.P.; Gupta, P.; Malik, R.; Tiwari, H.; Kulkarni, S.K. Indian J. Pharm. Sci., 2004, 66, 653.
144. Thamotharan, S.; Parthasarthi, V.; Malik, R.; Jindal, D.P.; Piplani, P.; Linden A. Acta Cryst., 2003, C59, 422.
145. Thamotharan, S.; Parthasarthi, V.; Malik, R.; Jindal, D.P.; Piplani, P.; Linden A. Acta Cryst., 2003, C59, 0514.